MARKET

SCNX

SCNX

Scienture Holdings, Inc
NASDAQ
0.4080
+0.0080
+2.00%
Opening 11:49 05/22 EDT
OPEN
0.4100
PREV CLOSE
0.4000
HIGH
0.4190
LOW
0.3900
VOLUME
193.12K
TURNOVER
--
52 WEEK HIGH
2.600
52 WEEK LOW
0.2382
MARKET CAP
16.58M
P/E (TTM)
-0.1803
1D
5D
1M
3M
1Y
5Y
1D
Scienture Holdings, Inc. GAAP EPS of -$0.08 beats by $0.15, revenue of $0.06M
Seeking Alpha · 4d ago
Scienture Holdings Q1 revenue jumps on Arbli sales, operating expenses steady
Reuters · 4d ago
SCIENTURE REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS AND BUSINESS UPDATE HIGHLIGHTED BY SIGNIFICANT REVENUE GROWTH AND GROSS MARGIN EXPANSION
Reuters · 4d ago
SCIENTURE HOLDINGS, INC Q1 GROSS PROFIT USD 54 THOUSAND
Reuters · 4d ago
Weekly Report: what happened at SCNX last week (0511-0515)?
Weekly Report · 4d ago
Scienture Holdings Q1 EPS $(0.08) Beats $(0.22) Estimate, Sales $56.325K Up From $10.258K YoY
Benzinga · 6d ago
Scienture Holdings: Q1 Earnings Snapshot
Barchart · 05/15 15:58
Weekly Report: what happened at SCNX last week (0504-0508)?
Weekly Report · 05/11 09:36
More
About SCNX
Scienture Holdings, Inc., through its wholly owned subsidiary, Scienture, LLC, is a specialty pharmaceutical company focused on providing enhanced value to patients, physicians and caregivers by offering specialty products to satisfy unmet market needs. Scienture, LLC is focused on developing and commercializing products for the treatment of central nervous system and cardiovascular diseases. Scienture LLC is developing a range of product candidates, including new potential treatments for hypertension, migraine, pain and thrombosis and other related disorders. The Company's product candidates include SCN- 102 (hypertension), SCN- 104 (CNS-Pain), SCN- 106 (Cardiovascular) and SCN- 107 (Pain). SCN-102 is an oral liquid formulation of losartan potassium in development for the treatment of hypertension. SCN-104 is a multi-dose pen-based delivery system for self-injection and increased patient convenience, which is in development for the acute treatment of migraine headaches.

Webull offers Scienture Holdings Inc stock information, including NASDAQ: SCNX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SCNX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SCNX stock methods without spending real money on the virtual paper trading platform.